Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Sign Up
Cited by 7

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Germline predisposition to clonal hematopoiesis

Liu, Jie, Osman, Afaf E.G., Bolton, Kelly, Godley, Lucy A.·2023·Leukemia Research
DOI 10.1016/j.leukres.2023.107344
Open this paper in CoChat — free account

Abstract

We now recognize that with aging, hematopoietic stem and progenitor cells (HSPCs) acquire mutations that confer a fitness advantage and clonally expand in a process now termed clonal hematopoiesis (CH). Because CH predisposes to a variety of health problems, including cancers, cardiovascular diseases, and inflammatory conditions, there is intense interest in the inherited alleles associated with the development of CH. DNA variants near TERT, SMC4, KPNA4, IL12A, CD164, and ATM confer the strongest associations. In this review, we discuss our current state of knowledge regarding germline predisposition to CH.

Overview

Integrity signals

Registry

Crossref · 10.1016/j.leukres.2023.107344

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 6 references

Research works printed but not linked: 52

  1. Genovese, 2014, Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence, N. Engl. J. Med., 371, 2477, 10.1056/NEJMoa1409405 · DOI · Paper page
  2. Jaiswal, 2014, Age-related clonal hematopoiesis associated with adverse outcomes, N. Engl. J. Med., 371, 2488, 10.1056/NEJMoa1408617 · DOI · Paper page
  3. Xie, 2014, Age-related mutations associated with clonal hematopoietic expansion and malignancies, Nat. Med., 20, 1472, 10.1038/nm.3733 · DOI · Paper page
  4. Mitchell, 2022, Clonal dynamics of haematopoiesis across the human lifespan, Nature, 606, 343, 10.1038/s41586-022-04786-y · DOI · Paper page
  5. Jaiswal, 2017, Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease, N. Engl. J. Med., 377, 111, 10.1056/NEJMoa1701719 · DOI · Paper page
  6. Desai, 2018, Somatic mutations precede acute myeloid leukemia years before diagnosis, Nat. Med., 24, 1015, 10.1038/s41591-018-0081-z · DOI · Paper page
  7. Dorsheimer, 2019, Association of mutations contributing to clonal hematopoiesis with prognosis in chronic ischemic heart failure, JAMA Cardiol., 4, 25, 10.1001/jamacardio.2018.3965 · DOI · Paper page
  8. Bolton, 2020, Cancer therapy shapes the fitness landscape of clonal hematopoiesis, Nat. Genet, 52, 1219, 10.1038/s41588-020-00710-0 · DOI · Paper page
  9. Zekavat, 2021, Hematopoietic mosaic chromosomal alterations increase the risk for diverse types of infection, Nat. Med., 27, 1012, 10.1038/s41591-021-01371-0 · DOI
  10. Kessler, 2022, Common and rare variant associations with clonal haematopoiesis phenotypes, Nature, 612, 301, 10.1038/s41586-022-05448-9 · DOI · Paper page
  11. Uddin, 2022, Germline genomic and phenomic landscape of clonal hematopoiesis in 323,112 individuals, medRxiv
  12. Vlasschaert, 2022, Association of clonal hematopoiesis of indeterminate potential with worse kidney function and anemia in two cohorts of patients with advanced chronic kidney disease, J. Am. Soc. Nephrol., 33, 985, 10.1681/ASN.2021060774 · DOI
  13. Bolton, 2021, Clonal hematopoiesis is associated with risk of severe Covid-19, Nat. Commun., 12, 5975, 10.1038/s41467-021-26138-6 · DOI
  14. Papaemmanuil, 2013, Clinical and biological implications of driver mutations in myelodysplastic syndromes, Blood, 122, 3616, 10.1182/blood-2013-08-518886 · DOI · Paper page
  15. Ley, 2013, Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia, N. Engl. J. Med., 368, 2059, 10.1056/NEJMoa1301689 · DOI · Paper page
  16. Khoury, 2022, The 5th edition of the world health organization classification of haematolymphoid tumours: myeloid and histiocytic/dendritic neoplasms, Leukemia, 36, 1703, 10.1038/s41375-022-01613-1 · DOI · Paper page
  17. Steensma, 2015, Clonal hematopoiesis of indeterminate potential and its distinction from myelodysplastic syndromes, Blood, 126, 9, 10.1182/blood-2015-03-631747 · DOI · Paper page
  18. Dawoud, 2020, Clonal myelopoiesis in the UK Biobank cohort: ASXL1 mutations are strongly associated with smoking, Leukemia, 34, 2660, 10.1038/s41375-020-0896-8 · DOI
  19. Zink, 2017, Clonal hematopoiesis, with and without candidate driver mutations, is common in the elderly, Blood, 130, 742, 10.1182/blood-2017-02-769869 · DOI · Paper page
  20. Kar, 2022, Genome-wide analyses of 200,453 individuals yield new insights into the causes and consequences of clonal hematopoiesis, Nat. Genet, 54, 1155, 10.1038/s41588-022-01121-z · DOI · Paper page
  21. Brown, 2022, Shared and distinct genetic etiologies for different types of clonal hematopoiesis, bioRxiv
  22. Zhou, 2016, Mosaic loss of chromosome Y is associated with common variation near TCL1A, Nat. Genet, 48, 563, 10.1038/ng.3545 · DOI
  23. Wright, 2017, Genetic variants associated with mosaic Y chromosome loss highlight cell cycle genes and overlap with cancer susceptibility, Nat. Genet, 49, 674, 10.1038/ng.3821 · DOI
  24. Loh, 2018, Insights into clonal haematopoiesis from 8,342 mosaic chromosomal alterations, Nature, 559, 350, 10.1038/s41586-018-0321-x · DOI · Paper page
  25. Terao, 2019, GWAS of mosaic loss of chromosome Y highlights genetic effects on blood cell differentiation, Nat. Commun., 10, 4719, 10.1038/s41467-019-12705-5 · DOI
  26. Thompson, 2019, Genetic predisposition to mosaic Y chromosome loss in blood, Nature, 575, 652, 10.1038/s41586-019-1765-3 · DOI
  27. Loh, 2020, Monogenic and polygenic inheritance become instruments for clonal selection, Nature, 584, 136, 10.1038/s41586-020-2430-6 · DOI · Paper page
  28. Terao, 2020, Chromosomal alterations among age-related haematopoietic clones in Japan, Nature, 584, 130, 10.1038/s41586-020-2426-2 · DOI
  29. Laurie, 2012, Detectable clonal mosaicism from birth to old age and its relationship to cancer, Nat. Genet, 44, 642, 10.1038/ng.2271 · DOI · Paper page
  30. Jacobs, 2012, Detectable clonal mosaicism and its relationship to aging and cancer, Nat. Genet, 44, 651, 10.1038/ng.2270 · DOI · Paper page
  31. Takahashi, 2017, Copy number alterations detected as clonal hematopoiesis of indeterminate potential, Blood Adv., 1, 1031, 10.1182/bloodadvances.2017007922 · DOI
  32. Tuke, 2020, Large copy-number variants in UK biobank caused by clonal hematopoiesis may confound penetrance estimates, Am. J. Hum. Genet, 107, 325, 10.1016/j.ajhg.2020.06.001 · DOI
  33. Pich, 2022, Discovering the drivers of clonal hematopoiesis, Nat. Commun., 13, 4267, 10.1038/s41467-022-31878-0 · DOI
  34. Churpek, 2015, Genomic analysis of germ line and somatic variants in familial myelodysplasia/acute myeloid leukemia, Blood, 126, 2484, 10.1182/blood-2015-04-641100 · DOI · Paper page
  35. Brown, 2020, RUNX1-mutated families show phenotype heterogeneity and a somatic mutation profile unique to germline predisposed AML, Blood Adv., 4, 1131, 10.1182/bloodadvances.2019000901 · DOI · Paper page
  36. Yu, 2023, Genomic landscape of patients with germline RUNX1 variants and familial platelet disorder with myeloid malignancy, bioRxiv
  37. Niroula, 2021, Distinction of lymphoid and myeloid clonal hematopoiesis, Nat. Med., 27, 1921, 10.1038/s41591-021-01521-4 · DOI
  38. Saiki, 2021, Combined landscape of single-nucleotide variants and copy number alterations in clonal hematopoiesis, Nat. Med., 27, 1239, 10.1038/s41591-021-01411-9 · DOI
  39. Guo, 2020, Mosaic loss of human Y chromosome: what, how and why, Hum. Genet, 139, 421, 10.1007/s00439-020-02114-w · DOI
  40. Weinstock, J.S. et al. Clonal hematopoiesis is driven by aberrant activation of TCL1A. bioRxiv, 2021.2012.2010.471810 (2021). https://doi.org:10.1101/2021.12.10.471810. · DOI
  41. Dawoud, 2022, Age-related loss of the Y chromosome is associated with sex hormone binding globulin and selected drivers of clonal hematopoiesis, medRxiv, 2022
  42. Dawoud, 2022, Clonal myelopoiesis promotes adverse outcomes in chronic kidney disease, Leukemia, 36, 507, 10.1038/s41375-021-01382-3 · DOI
  43. Wong, 2022, Clonal hematopoiesis and risk of chronic liver disease, medRxiv, 2022
  44. Park, 2010, Estimation of effect size distribution from genome-wide association studies and implications for future discoveries, Nat. Genet, 42, 570, 10.1038/ng.610 · DOI · Paper page
  45. Steensma, 2020, What to tell your patient with clonal hematopoiesis and why: insights from 2 specialized clinics, Blood, 136, 1623
  46. Gallì, 2021, Relationship between clone metrics and clinical outcome in clonal cytopenia, Blood, 138, 965, 10.1182/blood.2021011323 · DOI
  47. Weeks, 2023, Prediction of risk for myeloid malignancy in clonal hematopoiesis, NEJM Evid., 2, 1, 10.1056/EVIDoa2200310 · DOI · Paper page
  48. Ridker, 2017, Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial, Lancet, 390, 1833, 10.1016/S0140-6736(17)32247-X · DOI · Paper page
  49. Wong, 2020, Inhibition of IL1β by canakinumab may be effective against diverse molecular subtypes of lung cancer: an exploratory analysis of the CANTOS trial, Cancer Res, 80, 5597, 10.1158/0008-5472.CAN-19-3176 · DOI
  50. Gibson, 2022, Donor clonal hematopoiesis and recipient outcomes after transplantation, J. Clin. Oncol. Off. J. Am. Soc. Clin. Oncol., 40, 189, 10.1200/JCO.21.02286 · DOI · Paper page
  51. Bao, 2020, Inherited myeloproliferative neoplasm risk affects haematopoietic stem cells, Nature, 586, 769, 10.1038/s41586-020-2786-7 · DOI
  52. Silver, 2021, Germline risk of clonal haematopoiesis, Nat. Rev. Genet., 22, 603, 10.1038/s41576-021-00356-6 · DOI

Cited by

Metadata

Authors
Liu, J., Osman, A. E. G., Bolton, K., & Godley, L. A.
Venue
Leukemia Research
Publisher
Elsevier BV
Published
2023-09
Volume
132
Pages
107344
ISSN
0145-2126
DOI
10.1016/j.leukres.2023.107344
Cited by
7
References
6
Language
en
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review